Mapping the central effects of chronic ketamine administration in an adolescent primate model by functional magnetic resonance imaging (fMRI)

NeuroToxicology

Volumn 33, Issue 1, 2012, Pages 70-77

  Yu, Hongluan ^a   Li, Qi ^b   Wang, Defeng ^c   Shi, Lin ^c   Lu, Gang ^c   Sun, Lin ^a   Wang, Li ^a   Zhu, Wei ^a   Mak, Ying T ^c   Wong, Naikei ^b   Wang, Yixiang ^c   Pan, Fang ^a   Yew, David T ^c  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Dopamine; Functional magnetic resonance imaging (fMRI); Ketamine; Prefrontal cortex

Indexed keywords

DOPAMINE; GLUTAMIC ACID; KETAMINE; TYROSINE 3 MONOOXYGENASE;

ADOLESCENCE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; BOLD SIGNAL; BRAIN FUNCTION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; IMMUNOCHEMISTRY; LIMBIC CORTEX; LOCOMOTION; NONHUMAN; POSTERIOR CINGULATE; PREFRONTAL CORTEX; PRIMATE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; VISUAL CORTEX;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN MAPPING; CHOLINE O-ACETYLTRANSFERASE; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; EXCITATORY AMINO ACID ANTAGONISTS; IMAGE PROCESSING, COMPUTER-ASSISTED; KETAMINE; MACACA FASCICULARIS; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; MACACA FASCICULARIS; PRIMATES;

EID: 84155176898     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2011.11.001     Document Type: Article

References (57)

1. Aalto S., Hirvonen J., Kajander J., Scheinin H., Nagren K., Vilkman H., et al. Ketamine does not decrease striatal dopamine D2 receptor binding in man. Psychopharmacology (Berl) 2002, 164:401-406.
2. Abel K.M., Allin M.P., Kucharska-Pietura K., Andrew C., Williams S., David A.S., et al. Ketamine and fMRI BOLD signal: distinguishing between effects mediated by change in blood flow versus change in cognitive state. Hum Brain Mapp 2003, 18:135-145.
3. Becker A., Peters B., Schroeder H., Mann T., Huether G., Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:687-700.
4. Belforte J.E., Zsiros V., Sklar E.R., Jiang Z., Yu G., Li Y., et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 2010, 13:76-83.
5. Bustillo J.R., Lauriello J., Rowland L.M., Thomson L.M., Petropoulos H., Hammond R., et al. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure. Schizophr Res 2002, 58:313-321.
6. Cho R.Y., Konecky R.O., Carter C.S. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci USA 2006, 103:19878-19883.
7. Chou S.Y., Chen C.Y., Su H.W., Hsu M.I., Liang S.R., Hsu C.S. Ultrasonographic quantification of the endometrium during the menstrual cycle using computer-assisted analysis. Taiwan J Obstet Gynecol 2011, 50:297-300.
8. Crews F., He J., Hodge C. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav 2007, 86:189-199.
9. Ellison-Wright I., Bullmore E. Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr Res 2009, 108:3-10.
10. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 2005, 8:1481-1489.
11. Fang M., Li J., Lu G., Gong X., Yew D.T. A fMRI study of age-related differential cortical patterns during cued motor movement. Brain Topogr 2005, 17:127-137.
12. Finch D.M., Gigg J., Tan A.M., Kosoyan O.P. Neurophysiology and neuropharmacology of projections from entorhinal cortex to striatum in the rat. Brain Res 1995, 670:233-247.
13. Gainetdinov R.R., Mohn A.R., Bohn L.M., Caron M.G. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc Natl Acad Sci USA 2001, 98:11047-11054.
14. Guo N., Hwang D.R., Lo E.S., Huang Y.Y., Laruelle M., Abi-Dargham A. Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia. Neuropharmacology 2003, 28:1703-1711.
15. Haznedar M.M., Buchsbaum M.S., Hazlett E.A., Shihabuddin L., New A., Siever L.J. Cingulate gyrus volume and metabolism in the schizophrenia spectrum. Schizophr Res 2004, 71:249-262.
16. Heimer L. A new anatomical framework for neuropsychiatric disorders and drug abuse. Am J Psychiatry 2003, 160:1726-1739.
17. Hokfelt T., Johansson O., Fuxe K., Goldstein M., Park D. Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain II. Tyrosine hydroxylase in the telencephalon. Med Biol 1977, 55:21-40.
18. Homayoun H., Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 2007, 27:11496-11500.
19. Howard C.V.R.M. Unbiased stereology 2005, Garland Science/BIOS Scientific Publishers, New York.
20. Jentsch J.D., Redmond D.E., Elsworth J.D., Taylor J.R., Youngren K.D., Roth R.H. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 1997, 277:953-955.
21. Karson C.N., Mrak R.E., Husain M.M., Griffin W.S. Decreased mesopontine choline acetyltransferase levels in schizophrenia. Correlations with cognitive functions. Mol Chem Neuropathol 1996, 29:181-191.
22. Koch M., Schnitzler H.U. The acoustic startle response in rats-circuits mediating evocation, inhibition and potentiation. Behav Brain Res 1997, 89:35-49.
23. Kubler A., Murphy K., Garavan H. Cocaine dependence and attention switching within and between verbal and visuospatial working memory. Eur J Neurosci 2005, 21:1984-1992.
24. Lee C.U., Shenton M.E., Salisbury D.F., Kasai K., Onitsuka T., Dickey C.C., et al. Fusiform gyrus volume reduction in first-episode schizophrenia: a magnetic resonance imaging study. Arch Gen Psychiatry 2002, 59:775-781.
25. Lee H.W., Hong S.B., Seo D.W., Tae W.S., Hong S.C. Mapping of functional organization in human visual cortex: electrical cortical stimulation. Neurology 2000, 54:849-854.
26. Li Q., Cheung C., Wei R., Cheung V., Hui E.S., You Y., et al. Voxel-based analysis of postnatal white matter microstructure in mice exposed to immune challenge in early or late pregnancy. Neuroimage 2010, 52:1-8.
27. Li Q., Cheung C., Wei R., Hui E.S., Feldon J., Meyer U., et al. Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS One 2009, 4:e6354.
28. Liao Y., Tang J., Ma M., Wu Z., Yang M., Wang X., et al. Frontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging study. Brain 2010, 133:2115-2122.
29. Liu F., Garland M., Duan Y., Stark R.I., Xu D., Dong Z., et al. Study of the development of fetal baboon brain using magnetic resonance imaging at 3 Tesla. Neuroimage 2008, 40:148-159.
30. Maskos U. The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology. Br J Pharmacol 2008, 153(Suppl 1):S438-S445.
31. McAlonan G.M., Daly E., Kumari V., Critchley H.D., van Amelsvoort T., Suckling J., et al. Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain 2002, 125:1594-1606.
32. McCann U.D., Szabo Z., Seckin E., Rosenblatt P., Mathews W.B., Ravert H.T., et al. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB. Neuropharmacology 2005, 30:1741-1750.
33. Morgan C.J., Muetzelfeldt L., Curran H.V. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction 2010, 105:121-133.
34. Narendran R., Frankle W.G., Keefe R., Gil R., Martinez D., Slifstein M., et al. Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am J Psychiatry 2005, 162:2352-2359.
35. Nelson C.L., Burk J.A., Bruno J.P., Sarter M. Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats. Psychopharmacology (Berl) 2002, 161:168-179.
36. Newell K.A., Zavitsanou K., Jew S.K., Huang X.F. Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:225-233.
37. Nordquist R.E., Risterucci C., Moreau J.L., von Kienlin M., Kunnecke B., Maco M., et al. Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats. Neuropharmacology 2008, 54:405-416.
38. Park M.S., Sohn J.H., Suk J.A., Kim S.H., Sohn S., Sparacio R. Brain substrates of craving to alcohol cues in subjects with alcohol use disorder. Alcohol Alcohol 2007, 42:417-422.
39. Parks M.H., Morgan V.L., Pickens D.R., Price R.R., Dietrich M.S., Nickel M.K., et al. Brain fMRI activation associated with self-paced finger tapping in chronic alcohol-dependent patients. Alcohol Clin Exp Res 2003, 27:704-711.
40. Pearson J.M., Hayden B.Y., Raghavachari S., Platt M.L. Neurons in posterior cingulate cortex signal exploratory decisions in a dynamic multioption choice task. Curr Biol 2009, 19:1532-1537.
41. Ray R., Schnoll R.A., Lerman C. Nicotine dependence: biology, behavior, and treatment. Annu Rev Med 2009, 60:247-260.
42. Renshaw P.F., Yurgelun-Todd D.A., Cohen B.M. Greater hemodynamic response to photic stimulation in schizophrenic patients: an echo planar MRI study. Am J Psychiatry 1994, 151:1493-1495.
43. Robledo P., Koob G.F. Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat. Behav Brain Res 1993, 55:159-166.
44. Rujescu D., Bender A., Keck M., Hartmann A.M., Ohl F., Raeder H., et al. A pharmacological model for psychosis based on N-methyl-d-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry 2006, 59:721-729.
45. See R.E., Elliott J.C., Feltenstein M.W. The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats. Psychopharmacology (Berl) 2007, 194:321-331.
46. Sesack S.R., Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 1992, 320:145-160.
47. Stefani M.R., Moghaddam B. Transient N-methyl-d-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol Psychiatry 2005, 57:433-436.
48. Stoet G., Snyder L.H. Effects of the NMDA antagonist ketamine on task-switching performance: evidence for specific impairments of executive control. Neuropharmacology 2006, 31:1675-1681.
49. Theberge J., Al-Semaan Y., Drost D.J., Malla A.K., Neufeld R.W., Bartha R., et al. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla. Psychiatry Res 2004, 131:107-114.
50. Vallortigara G., Rogers L.J., Bisazza A. Possible evolutionary origins of cognitive brain lateralization. Brain Res Brain Res Rev 1999, 30:164-175.
51. Volkow N.D., Wang G.J., Telang F., Fowler J.S., Logan J., Childress A.R., et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 2006, 26:6583-6588.
52. 18F]fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol 1997, 7:9-24.
53. Wei J., Ma J.Z., Payne T.J., Cui W., Ray R., Mitra N., et al. Replication and extension of association of choline acetyltransferase with nicotine dependence in European and African American smokers. Hum Genet 2010, 127:691-698.
54. Willson M.C., Wilman A.H., Bell E.C., Asghar S.J., Silverstone P.H. Dextroamphetamine causes a change in regional brain activity in vivo during cognitive tasks: a functional magnetic resonance imaging study of blood oxygen level-dependent response. Biol Psychiatry 2004, 56:284-291.
55. Yilmaz A., Schulz D., Aksoy A., Canbeyli R. Prolonged effect of an anesthetic dose of ketamine on behavioral despair. Pharmacol Biochem Behav 2002, 71:341-344.
56. Yoon J.H., Maddock R.J., Rokem A., Silver M.A., Minzenberg M.J., Ragland J.D., et al. GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J Neurosci 2010, 30:3777-3781.
57. Yu F.Y., Lu S.B., Huang L.H., Xu W.J., Peng J., Zhao B., et al. Mechanisms of autologous chondrocytes mass transplantation in the repair of cartilage defects of rabbits' knee. Zhongguo Gu Shang 2010, 23:683-687.